Roche Holding AG (0QOK) Share Forecast & Price Target

Compare

34 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0QOK Analyst Ratings

Moderate Buy

6 Buy

4 Hold

2 Sell

Based on 12 analysts giving stock ratings to

Roche

Holding AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0QOK Stock 12 Month Forecast

Average Price Target

CHF346.63

▼(-3.39% Downside)

Based on 12 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is CHF346.63 with a high forecast of CHF410.00 and a low forecast of CHF230.00. The average price target represents a -3.39% change from the last price of CHF358.80.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"228":"CHF228","319":"CHF319","410":"CHF410","273.5":"CHF273.5","364.5":"CHF364.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":409.9999985860248,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF410.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":346.6338078563,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF346.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":229.9999992067944,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF230.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[228,273.5,319,364.5,410],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,362.9,366.5230768143096,370.1461536286192,373.7692304429288,377.3923072572384,381.015384071548,384.63846088585757,388.2615377001672,391.88461451447677,395.5076913287864,399.13076814309596,402.7538449574056,406.37692177171516,{"y":409.9999985860248,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,362.9,361.6487544504846,360.3975089009692,359.14626335145385,357.8950178019384,356.64377225242305,355.3925267029077,354.1412811533923,352.8900356038769,351.63879005436155,350.3875445048461,349.13629895533074,347.88505340581537,{"y":346.6338078563,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,362.9,352.6769230159072,342.4538460318145,332.23076904772176,322.007692063629,311.7846150795363,301.56153809544355,291.33846111135085,281.1153841272581,270.89230714316534,260.66923015907264,250.44615317497988,240.22307619088713,{"y":229.9999992067944,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":288.31,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":292.587,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":270.128,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":265.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":258.651,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":258.028,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":259.632,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":280.254,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":258.861,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 19</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":308.645,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":328.134,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 40, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":354.553,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 39, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":362.9,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF410.00

Average Price TargetCHF346.63

Lowest Price TargetCHF230.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

James Gordon CFA

Barclays

CHF410

Buy

14.27%

Upside

Reiterated

03/03/26

Barclays Keeps Their Buy Rating on Roche Holding AG (RHHVF)

Richard Vosser

J.P. Morgan

CHF350

Hold

-2.45%

Downside

Reiterated

03/02/26

Analysts Offer Insights on Healthcare Companies: 10x Genomics (NASDAQ: TXG), Ascendis Pharma (NASDAQ: ASND) and Roche Holding AG (Other OTC: RHHVF)

Sarita Kapila

Morgan Stanley

CHF295

Sell

-17.78%

Downside

Reiterated

03/02/26

Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating

Graham Parry

Citi

CHF368.2→CHF400

Buy

11.48%

Upside

Reiterated

02/20/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (NYSE: HIMS), Roche Holding AG (Other OTC: RHHVF) and Amylyx Pharmaceuticals Inc (NASDAQ: AMLX)

Luisa Hector

Berenberg Bank

CHF320→CHF340

Hold

-5.24%

Downside

Reiterated

02/18/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Incyte (NASDAQ: INCY) and Moderna (NASDAQ: MRNA)

Emmanuel Papadakis

Deutsche Bank

CHF340

Hold

-5.24%

Downside

Reiterated

02/17/26

Roche Holding AG (RHHVF) Gets a Hold from Deutsche Bank

Michael Leuchten

Jefferies

CHF230

Sell

-35.90%

Downside

Reiterated

02/16/26

Jefferies Remains a Sell on Roche Holding AG (RHHVF)

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

02/02/26

Analysts' Top Healthcare Picks: Nektar Therapeutics (NKTR), Roche Holding AG (RHHVF)

Matthew Weston

UBS

CHF384

Buy

7.02%

Upside

Reiterated

01/30/26

Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Roche Holding AG (Other OTC: RHHVF) and Zimmer Biomet Holdings (NYSE: ZBH)

Justin Smith

Bernstein

CHF400

Buy

11.48%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Halozyme (NASDAQ: HALO) and Elevance Health (NYSE: ELV)

David Evans

Kepler Capital

CHF315

Buy

-12.21%

Downside

Reiterated

01/29/26

Analysts Conflicted on These Healthcare Names: Revolution Medicines (NASDAQ: RVMD), Roche Holding AG (Other OTC: RHHVF) and Incyte (NASDAQ: INCY)

James Quigley

Goldman Sachs

CHF365→CHF349

Hold

-2.73%

Downside

Reiterated

01/27/26

Roche Holding AG (RHHVF) Gets a Hold from Goldman Sachs

Rajesh Kumar

HSBC

CHF285→CHF320

Buy

-10.81%

Downside

Upgraded

10/01/25

HSBC upgrades Roche Holding AG (RHHVF) to a Buy

Peter Verdult

Exane BNP Paribas

CHF300

Buy

-16.39%

Downside

Initiated

04/16/25

BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

James Gordon CFA

Barclays

CHF410

Buy

14.27%

Upside

Reiterated

03/03/26

Barclays Keeps Their Buy Rating on Roche Holding AG (RHHVF)

Richard Vosser

J.P. Morgan

CHF350

Hold

-2.45%

Downside

Reiterated

03/02/26

Analysts Offer Insights on Healthcare Companies: 10x Genomics (NASDAQ: TXG), Ascendis Pharma (NASDAQ: ASND) and Roche Holding AG (Other OTC: RHHVF)

Sarita Kapila

Morgan Stanley

CHF295

Sell

-17.78%

Downside

Reiterated

03/02/26

Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating

Graham Parry

Citi

CHF368.2→CHF400

Buy

11.48%

Upside

Reiterated

02/20/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (NYSE: HIMS), Roche Holding AG (Other OTC: RHHVF) and Amylyx Pharmaceuticals Inc (NASDAQ: AMLX)

Luisa Hector

Berenberg Bank

CHF320→CHF340

Hold

-5.24%

Downside

Reiterated

02/18/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Incyte (NASDAQ: INCY) and Moderna (NASDAQ: MRNA)

Emmanuel Papadakis

Deutsche Bank

CHF340

Hold

-5.24%

Downside

Reiterated

02/17/26

Roche Holding AG (RHHVF) Gets a Hold from Deutsche Bank

Michael Leuchten

Jefferies

CHF230

Sell

-35.90%

Downside

Reiterated

02/16/26

Jefferies Remains a Sell on Roche Holding AG (RHHVF)

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

02/02/26

Analysts' Top Healthcare Picks: Nektar Therapeutics (NKTR), Roche Holding AG (RHHVF)

Matthew Weston

UBS

CHF384

Buy

7.02%

Upside

Reiterated

01/30/26

Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Roche Holding AG (Other OTC: RHHVF) and Zimmer Biomet Holdings (NYSE: ZBH)

Justin Smith

Bernstein

CHF400

Buy

11.48%

Upside

Reiterated

01/29/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Halozyme (NASDAQ: HALO) and Elevance Health (NYSE: ELV)

David Evans

Kepler Capital

CHF315

Buy

-12.21%

Downside

Reiterated

01/29/26

Analysts Conflicted on These Healthcare Names: Revolution Medicines (NASDAQ: RVMD), Roche Holding AG (Other OTC: RHHVF) and Incyte (NASDAQ: INCY)

James Quigley

Goldman Sachs

CHF365→CHF349

Hold

-2.73%

Downside

Reiterated

01/27/26

Roche Holding AG (RHHVF) Gets a Hold from Goldman Sachs

Rajesh Kumar

HSBC

CHF285→CHF320

Buy

-10.81%

Downside

Upgraded

10/01/25

HSBC upgrades Roche Holding AG (RHHVF) to a Buy

Peter Verdult

Exane BNP Paribas

CHF300

Buy

-16.39%

Downside

Initiated

04/16/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding AG

3 Months

xxx

Success Rate

14/17 ratings generated profit

Average Return

+9.52%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 82.35% of your transactions generating a profit, with an average return of +9.52% per trade.

1 Year

Matthew WestonUBS

Success Rate

11/11 ratings generated profit

Average Return

+34.53%

reiterated a buy rating last month

Copying Matthew Weston's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +34.53% per trade.

2 Years

xxx

Success Rate

14/14 ratings generated profit

Average Return

+39.68%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +39.68% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QOK Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0QOK has received 34 Buy Ratings, 34 Hold Ratings, and 5 Sell Ratings. 0QOK average Analyst price target in the past 3 months is 346.63.

Each month's total comprises the sum of three months' worth of ratings.

0QOK Financial Forecast

0QOK Earnings Forecast

Next quarter’s earnings estimate for 0QOK is CHF10.76 with a range of CHF10.71 to CHF10.80. The previous quarter’s EPS was CHF8.38. 0QOK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.

0QOK Sales Forecast

Next quarter’s sales forecast for 0QOK is CHF31.20B with a range of CHF30.87B to CHF31.53B. The previous quarter’s sales results were CHF30.57B. 0QOK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.

0QOK Stock Forecast FAQ

What is GB:0QOK’s average 12-month price target, according to analysts?

Based on analyst ratings, Roche Holding AG’s 12-month average price target is 346.63.

What is GB:0QOK’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for GB:0QOK, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Roche Holding AG a Buy, Sell or Hold?

Roche Holding AG has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 4 hold ratings and 2 sell ratings.

What is Roche Holding AG’s share price target?

The average share price target for Roche Holding AG is 346.63. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF410.00 ,and the lowest forecast is CHF230.00. The average share price target represents -3.39% Decrease from the current price of CHF358.8.

What do analysts say about Roche Holding AG?

Roche Holding AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Roche Holding AG?

To buy shares of GB:0QOK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Roche Holding AG (0QOK) Share Forecast & Price Target

0QOK Analyst Ratings

0QOK Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Roche Holding AG

0QOK Analyst Recommendation Trends

0QOK Financial Forecast

0QOK Earnings Forecast

0QOK Sales Forecast

0QOK Stock Forecast FAQ

Detailed List of Analyst Forecasts